Adage Capital Partners GP L.L.C. Grows Stock Position in Health Catalyst, Inc. $HCAT

Adage Capital Partners GP L.L.C. lifted its stake in Health Catalyst, Inc. (NASDAQ:HCAT - Free Report) by 114.4% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 159,280 shares of the company's stock after purchasing an additional 85,000 shares during the quarter. Adage Capital Partners GP L.L.C. owned about 0.23% of Health Catalyst worth $722,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently made changes to their positions in HCAT. Price T Rowe Associates Inc. MD increased its holdings in shares of Health Catalyst by 8.3% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 62,443 shares of the company's stock valued at $442,000 after purchasing an additional 4,798 shares during the last quarter. Northern Trust Corp increased its holdings in shares of Health Catalyst by 8.5% in the fourth quarter. Northern Trust Corp now owns 526,607 shares of the company's stock valued at $3,723,000 after purchasing an additional 41,298 shares during the last quarter. BNP Paribas Financial Markets acquired a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $735,000. Brevan Howard Capital Management LP acquired a new stake in shares of Health Catalyst in the fourth quarter valued at approximately $92,000. Finally, Cubist Systematic Strategies LLC increased its holdings in shares of Health Catalyst by 34.9% in the fourth quarter. Cubist Systematic Strategies LLC now owns 137,670 shares of the company's stock valued at $973,000 after purchasing an additional 35,584 shares during the last quarter. Institutional investors and hedge funds own 85.00% of the company's stock.

Health Catalyst Trading Down 3.4%

Shares of NASDAQ HCAT traded down $0.11 during trading on Friday, reaching $3.13. The stock had a trading volume of 776,691 shares, compared to its average volume of 853,648. Health Catalyst, Inc. has a fifty-two week low of $2.52 and a fifty-two week high of $9.24. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.83 and a current ratio of 1.83. The business's 50-day moving average price is $3.51 and its 200-day moving average price is $3.86. The company has a market cap of $220.27 million, a P/E ratio of -2.07 and a beta of 1.53.

Analysts Set New Price Targets

Several research firms recently commented on HCAT. Evercore ISI increased their price target on Health Catalyst from $3.00 to $4.00 and gave the company an "in-line" rating in a report on Thursday, August 28th. Canaccord Genuity Group cut their price target on Health Catalyst from $9.00 to $5.00 and set a "buy" rating for the company in a report on Friday, August 29th. Cantor Fitzgerald reissued a "neutral" rating and set a $4.00 target price (down previously from $9.00) on shares of Health Catalyst in a research note on Friday, August 8th. Citigroup cut Health Catalyst from a "buy" rating to a "neutral" rating and cut their target price for the stock from $6.50 to $3.50 in a research note on Friday, August 8th. Finally, Wells Fargo & Company cut their target price on Health Catalyst from $10.00 to $6.00 and set an "overweight" rating for the company in a research note on Monday, August 11th. Three equities research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, Health Catalyst currently has an average rating of "Hold" and a consensus price target of $4.73.

Health Catalyst Company Profile

Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.